Karyopharm Therapeutics (KPTI) EPS (Basic) (QoQ) (2013 - 2025)
Karyopharm Therapeutics (KPTI) EPS (Basic) (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Karyopharm Therapeutics | 53.25 Mn | 53.25 Mn | 32.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 414.43% |
| Sep 30, 2025 | 11.58% |
| Jun 30, 2025 | -56.01% |
| Mar 31, 2025 | -149.29% |
| Dec 31, 2024 | 246.05% |
| Sep 30, 2024 | -130,613.16% |
| Jun 30, 2024 | 160.75% |
| Mar 31, 2024 | -136.53% |
| Dec 31, 2023 | 393.70% |
| Sep 30, 2023 | -5.57% |
| Jun 30, 2023 | 4.99% |
| Mar 31, 2023 | 37.56% |
| Dec 31, 2022 | -6.35% |
| Sep 30, 2022 | 26.48% |
| Jun 30, 2022 | -15.41% |
| Mar 31, 2022 | -203.68% |
| Dec 31, 2021 | 174.97% |
| Sep 30, 2021 | 3.65% |
| Jun 30, 2021 | 99.91% |
| Mar 31, 2021 | -148.08% |